How many patents does
Chemocentryx have?
patents
921
families
75
granted
238
applications
683
US
201
EP
104
CN
56
WO
41
JP
37
KR
35
RoW
447
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Chemocentryx
Top ten assignees appearing on patents
2009 - 2018
| chemocentryx | 794 |
| charo, israel | 8 |
| glaxosmithkline intellectual prope… 🛈 | 3 |
| glaxo group | 2 |
| tularik | 2 |
| chemocentrix | 1 |
2009
| chemocentryx | 75 |
| tularik | 2 |
2018
| chemocentryx | 94 |
| charo, israel | 2 |
Chemocentryx
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| c5ar antagonists | 46 | 2008 |
| triazolyl phenyl benzenesulfonamides | 42 | 2006 |
| 3-(imidazolyl)-pyrazolo[3,4-b]pyridines | 36 | 2007 |
| aryl sulfonamides | 34 | 2002 |
| azaindazole compounds and methods of use | 34 | 2005 |
| n-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides | 33 | 2007 |
| fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the tream… 🛈 | 33 | 2007 |
| pyrazol-1-yl benzene sulfonamides as ccr9 antagonists | 31 | 2012 |
| cxcr7 antagonists | 27 | 2012 |
| antagonists of chemokine receptors | 27 | 2012 |